EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Microbiome-based therapies for Parkinson’s disease

Mudassir Alam, Kashif Abbas, Mohd Mustafa, Nazura Usmani, Safia Habib

Frontiers in Nutrition · 06.11.2024 · 11

DOI: 10.3389/fnut.2024.1496616 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Nutrition, online erschienen am 06.11.2024. Verfasst von Mudassir Alam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Indian Biological Sciences and Research Institute (IBRI), Noida, India. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 184 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human gut microbiome dysbiosis plays an important role in the pathogenesis of Parkinson’s disease (PD). The bidirectional relationship between the enteric nervous system (ENS) and central nervous system (CNS) under the mediation of the gut-brain axis control the gastrointestinal functioning. This review article discusses key mechanisms by which modifications in the composition and function of the gut microbiota (GM) influence PD progression and motor control loss. Increased intestinal permeability, chronic inflammation, oxidative stress, α-synuclein aggregation, and neurotransmitter imbalances are some key factors that govern gastrointestinal pathology and PD progression. The bacterial taxa of the gut associated with PD development are discussed with emphasis on the enteric nervous system (ENS), as well as the impact of gut bacteria on dopamine production and levodopa metabolism. The pathophysiology and course of the disease are associated with several inflammatory markers, including TNF-α, IL-1β, and IL-6. Emerging therapeutic strategies targeting the gut microbiome include probiotics, prebiotics, synbiotics, postbiotics, and fecal microbiota transplantation (FMT). The article explored how dietary changes may affect the gut microbiota (GM) and the ways that can affect Parkinson’s disease (PD), with a focus on nutrition-based, Mediterranean, and ketogenic diets. This comprehensive review synthesizes current evidence on the role of the gut microbiome in PD pathogenesis and explores its potential as a therapeutic target. Understanding these complex interactions may assist in the development of novel diagnostic tools and treatment options for this neurodegenerative disorder.

Schlagwörter

Stichwörter der Autor:innen

FMTParkinson’s diseaseenteric nervous systemgut dysbiosisgut microbiota

Autor:innen und Institutionen

  • Indian Biological Sciences and Research Institute (IBRI), Noida, India.
  • Department of Zoology, Faculty of Life Sciences, Aligarh Muslim University, Aligarh, India.
  • Department of Biochemistry, J.N. Medical College, Aligarh Muslim University, Aligarh, India.

Zitieren

APA

Alam, M., Abbas, K., Mustafa, M., Usmani, N., & Habib, S. (2024). Microbiome-based therapies for Parkinson’s disease. Frontiers in Nutrition, 11. https://doi.org/10.3389/fnut.2024.1496616

Vancouver

Alam M, Abbas K, Mustafa M, Usmani N, Habib S. Microbiome-based therapies for Parkinson’s disease. Frontiers in Nutrition. 2024;11. doi:10.3389/fnut.2024.1496616

BibTeX
@article{Alam2024,
  author = {Alam, Mudassir and Abbas, Kashif and Mustafa, Mohd and Usmani, Nazura and Habib, Safia},
  title = {Microbiome-based therapies for Parkinson’s disease},
  journal = {Frontiers in Nutrition},
  year = {2024},
  volume = {11},
  doi = {10.3389/fnut.2024.1496616}
}
Kostenlos starten →